CCL

Összesen 5 találat.
#/oldal:
Részletezés:
Rendezés:

1.

001-es BibID:BIBFORM108005
035-os BibID:(cikkazonosító)349 (Scopus)85148850132 (WoS)000938286900001
Első szerző:Kardos Zsófia
Cím:Tocilizumab in Combination with Corticosteroids in COVID-19 Pneumonia : a Single-centre Retrospective Controlled Study / Zsófia Kardos, Miklós Szabó, Zsuzsanna Baráth, Ágnes Miksi, Csaba Oláh, Ádám Kozma, József A. Gergely, Eszter Csánky, Zoltán Szekanecz
Dátum:2023
ISSN:2227-9059
Megjegyzések:Abstract: Introduction: Interleukin 6 receptor inhibition by tocilizumab (TCZ) has been effectively used worldwide for the treatment of multisystem inflammatory syndrome (MIS) associated with COVID-19. In this single centre study, we compared the outcome of COVID-19 pneumonia in TCZ treated vs. untreated (control) patients. We wished to compare TCZ administration in the general ward vs. in the intensive care unit (ICU). We also studied the role of a consulting rheumatologist in the management of severe COVID-19 pneumonia. Patients and methods: In our patients, COVID 19 pneumonia was confirmed by SARS-CoV-2 PCR, chest X-ray, and CT. We compared patients selected for TCZ treatment with TCZ-untreated age- and sex-matched controls. All patients received corticosteroids. In the TCZ-treated group, patients received one or two doses of TCZ 8 mg/kg IV in combination with corticosteroids. We recorded age, sex, symptom duration, oxygen saturation (SaO2), partial arterial oxygen pressure (PaO2), total white blood cell (WBC), absolute neutrophil, absolute lymphocyte and platelet counts, CRP, ferritin, IL-6, LDH, procalcitonin (PCT), and D-di mer. The primary outcome parameters were the need for ICU, ventilation, death, and time of hos pitalisation. Results: Altogether, 104 patients, 52 TCZ-treated and 52 TCZ-untreated, were included in this study. At baseline, the TCZ-treated patient group indeed had more pronounced COVID-19- related MIS compared to controls. Consultation with a rheumatologist was performed in 60% vs. 40% of cases. Nineteen patients (37%) received one, while 33 (63%) received two TCZ doses. TCZ was administered to 28 patients (54%) in the general ward and to 24 (46%) in the ICU. TCZ treatment was found to be safe in our COVID-19 pneumonia patients. TCZ treatment favourably influenced MIS biomarkers, and was associated with better clinical outcomes compared to controls. Patients receiving TCZ treatment in combination with corticosteroids already in the general ward exerted much better outcomes than those treated in the ICU. Consultation with a rheumatologist also im proved outcome. Conclusions: We successfully used TCZ in combination with corticosteroids in Hungarian COVID-19 pneumonia patients. We pointed out the importance of early treatment al ready in the general ward, and the involvement of a rheumatologist in making treatment decisions.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
COVID-19
IL-6 receptor
tocilizumab
pneumonia
efficacy
Megjelenés:Biomedicines. - 11 : 2 (2023), p. 1-15. -
További szerzők:Szabó Miklós (1980-) (tüdőgyógyász) Baráth Zsuzsa Miksi Ágnes Oláh Csaba (1972-) (idegsebész) Kozma Ádám Gergely József A. Csánky Eszter (1959-) (tüdőgyógyász, klinikai immunológus, allergológus) Szekanecz Zoltán (1964-) (reumatológus, belgyógyász, immunológus)
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

2.

001-es BibID:BIBFORM054431
Első szerző:Kerekes György (belgyógyász, kardiológus, angiológus)
Cím:Rheumatoid arthritis and metabolic syndrome / György Kerekes, Michael T. Nurmohamed, Miguel A. González-Gay, Ildikó Seres, György Paragh, Zsófia Kardos, Zsuzsa Baráth, László Tamási, Pál Soltész, Zoltán Szekanecz
Dátum:2014
ISSN:1759-4790 1759-4804
Megjegyzések:Rheumatoid arthritis (RA), especially active disease, is associated with considerable changes in body composition, lipids, adipokines and insulin sensitivity. Metabolic changes, such as increased total cholesterol, LDL cholesterol and triglyceride levels, occur even in preclinical RA. Active RA is associated with decreased lipid levels, BMI, fat and muscle mass, as well as altered lipid profiles. Some of these changes are also seen in metabolic syndrome, and could increase cardiovascular mortality. Importantly, the systemic inflammation underlying RA is an independent risk factor for cardiovascular disease. This Perspectives article summarizes data on the associations of various components of metabolic syndrome with RA, and discusses the effects of biologic therapy on these factors. The authors propose that components of metabolic syndrome should be monitored in patients with RA throughout the disease course, and argue that optimal disease control using biologic agents might attenuate several adverse effects of metabolic syndrome in these patients.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
undifferentiated connetice tissue disease
entholtelial cell markers
endothelial dísfunction
flow-mediated vasodilation
accelered atherosclerosis
Megjelenés:Nature Reviews Rheumatology 10 : 11 (2014), p. 691-696. -
További szerzők:Nurmohamed, Michael T. Gonzalez-Gay, Miguel A. Seres Ildikó Paragh György (1953-) (belgyógyász) Kardos Zsófia Baráth Zsuzsa Tamási László Soltész Pál (1961-) (belgyógyász, kardiológus) Szekanecz Zoltán (1964-) (reumatológus, belgyógyász, immunológus)
Pályázati támogatás:TÁMOP-4.2.2.A-11/1/KONV-2012-0031
TÁMOP
TÁMOP-4.2.2.A-11/1/KONV-2012-0031
TÁMOP
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

3.

001-es BibID:BIBFORM081586
Első szerző:Oláh Csaba (idegsebész)
Cím:Assessment of cognitive function in female rheumatoid arthritis patients : associations with cerebrovascular pathology, depression and anxiety / Oláh Csaba, Kardos Zsófia, Andrejkovics Mónika, Szarka Enikő, Hodosi Katalin, Domján Andrea, Sepsi Marianna, Sas Attila, Kostyál László, Fazekas Katalin, Flórián Ágnes, Lukács Katalin, Miksi Ágnes, Baráth Zsuzsanna, Kerekes György, Péntek Márta, Valikovics Attila, Tamási László, Bereczki Dániel, Szekanecz Zoltán
Dátum:2020
ISSN:0172-8172 1437-160X
Megjegyzések:We assessed cognitive function of female rheumatoid arthritis (RA) patients and analyze the determinants, with special focus on cerebrovascular morphology. Sixty methotrexate (MTX-) or biologic-treated RA patients and 39 healthy controls were included in a cross-sectional study. Smoking habits, alcohol intake and time spent in education were recorded. Standard measures were performed to assess cognitive function (Montreal Cognitive Assessment, MOCA; Trail Making Test, TMT; Victoria Stroop Test, VST; Wechsler Adult Intelligence Scale, WAIS; Benton Visual Retention test, BVRT), depression (Beck Depression Inventory, BDI), anxiety (State-Trait Anxiety Inventory, STAIT/S) and general health status (Short Form 36, SF-36). Mean disease activity (28-joint Disease Activity Score, mDAS28; erythrocyte sedimentation rate, mESR; C-reactive protein, mCRP) of the past 12 months was calculated; anti-cyclic citrullinated peptide (CCP) and rheumatoid factor (RF) were assessed. Cerebral vascular lesions and atrophy, carotid intima?media thickness (cIMT) and plaques, as well as median cerebral artery (MCA) circulatory reserve capacity (CRC) were assessed by brain magnetic resonance imaging (MRI), carotid ultrasound and transcranial Doppler, respectively. Cognitive function tests showed impairment in RA vs controls. Biologic- vs MTX-treated subgroups differed in TMT-A. Correlations were identified between cognitive function and depression/anxiety tests. WAIS, STAIS, STAIT and BDI correlated with most SF-36 domains. Numerous cognitive tests correlated with age and lower education. Some also correlated with disease duration, mESR and mDAS28. Regarding vascular pathophysiology, cerebral vascular lesions were associated with VST-A, carotid plaques with multiple cognitive parameters, while MCA and CRC with MOCA, BVRT and BDI. RA patients have significant cognitive impairment. Cognitive dysfunction may occur together with or independently of depression/anxiety. Older patients and those with lower education are at higher risk to develop cognitive impairment. Cognitive screening might be a useful tool to identify subgroups to be further investigated for cerebrovascular pathologies.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Rheumatoid arthritis
Cognitive dysfunction
Cerebrovascular disease
Transcranial Doppler
Carotid artery
Methotrexate
Biological therapy
Megjelenés:Rheumatology International. - 40 : 4 (2020), p. 529-540. -
További szerzők:Kardos Zsófia Andrejkovics Mónika (1967-) (klinikai szakpszichológus, neuropszichológus, pszichoterapeuta) Szarka Enikő Hódosi Katalin Domján Andrea (1979-) (jogász, egészségügyi menedzser) Sepsi Marianna Sas Attila Kostyál László (1974-) (radiológus) Fazekas Katalin (orvos) Flórián Ágnes Lukács Katalin Miksi Ágnes Baráth Zsuzsa Kerekes György (1973-) (belgyógyász, kardiológus, angiológus) Péntek Márta Valikovics Attila Tamási László Bereczki Dániel (1960-) (neurológus) Szekanecz Zoltán (1964-) (reumatológus, belgyógyász, immunológus)
Pályázati támogatás:TAMOP-4.2.4.A/2-11/1-2012-0001
TÁMOP
GINOP-2.3.2-15-2016-00050
GINOP
GINOP-2.3.2-15-2016-00015
GINOP
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

4.

001-es BibID:BIBFORM063076
Első szerző:Szekanecz Zoltán (reumatológus, belgyógyász, immunológus)
Cím:Autoimmune atherosclerosis in 3D : how it develops, how to diagnose and what to do / Zoltán Szekanecz, György Kerekes, Edit Végh, Zsófia Kardos, Zsuzsa Baráth, László Tamási, Yehuda Shoenfeld
Dátum:2016
ISSN:1568-9972
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:Autoimmunity Reviews 15 : 7 (2016), p.756-769. -
További szerzők:Kerekes György (1973-) (belgyógyász, kardiológus, angiológus) Végh Edit (1978-) (reumatológus, belgyógyász) Kardos Zsófia Baráth Zsuzsa Tamási László Shoenfeld, Yehuda
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

5.

001-es BibID:BIBFORM059757
Első szerző:Szekanecz Zoltán (reumatológus, belgyógyász, immunológus)
Cím:Mechanisms of Inflammatory Atherosclerosis in Rheumatoid Arthritis / Zoltán Szekanecz, György Kerekes, Zsófia Kardos, Zsuzsa Baráth, László Tamási
Dátum:2016
Megjegyzések:Cardiovascular disease dependent on inflammatory accelerated atherosclerosis leads to increased mortality in rheumatoid arthritis (RA). In addition to traditional, Framingham risk factors, several immuno-inflammatory cells, mediators and molecules may link atherosclerosis to arthritis. Among immune cells, primarily TH1 cells, as well as endothelial cells play a crucial role in synovial and vascular inflammation. Various cell surface molecules, such as adhesion receptors, CD40-CD40 ligand or members of the RANK-RANK ligand-osteoprotegerin system, as well as soluble pro-inflammatory cytokines, chemokines, autoantibodies and proteases have been implicated in RA and vascular damage. The early assessment of atherosclerosis and early intervention would decrease cardiovascular risk in RA.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Atherosclerosis
biologics
cardiovascular disease
chemokines
cytokines
DMARDs
endothelial cells
proteases
RANK ligand
rheumatoid arthritis
Megjelenés:Current Immunology Reviews. - 12 : 1 (2016), p. 35-46. -
További szerzők:Kerekes György (1973-) (belgyógyász, kardiológus, angiológus) Kardos Zsófia Baráth Zsuzsa Tamási László
Pályázati támogatás:TÁMOP-4.2.2.A-11/1/KONV-2012-0031
TÁMOP
TÁMOP-4.2.4.A/2-11-1-2012-0001
TÁMOP
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Rekordok letöltése1 
Corvina könyvtári katalógus v8.2.27 © 2023 Monguz kft. Minden jog fenntartva.